Cancer Research Targets  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 7203, August 1, 2007. doi: 10.1158/0008-5472.CAN-07-0473
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jarzynka, M. J.
Right arrow Articles by Cheng, S.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jarzynka, M. J.
Right arrow Articles by Cheng, S.-Y.

Cell, Tumor, and Stem Cell Biology

ELMO1 and Dock180, a Bipartite Rac1 Guanine Nucleotide Exchange Factor, Promote Human Glioma Cell Invasion

Michael J. Jarzynka1,2, Bo Hu1,3, Kwok-Min Hui1,2, Ifat Bar-Joseph1,2, Weisong Gu4, Takanori Hirose5, Lisa B. Haney7, Kodi S. Ravichandran7, Ryo Nishikawa6 and Shi-Yuan Cheng1,2

1 Cancer Institute and Departments of 2 Pathology and 3 Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania; 4 Ohio Supercomputer Center-Springfield, Springfield, Ohio; Departments of 5 Pathology and 6 Neurosurgery, Saitama Medical University, Moroyama-machi, Iruma-gun, Saitama, Japan; and 7 Beirne Carter Center for Immunology Research and Department of Microbiology, University of Virginia, Charlottesville, Virginia

Requests for reprints: Shi-Yuan Cheng, Cancer Institute and Department of Pathology, University of Pittsburgh, HCCLB, 2.26f, 5117 Centre Avenue, Pittsburgh, PA 15213. Phone: 412-623-3261; Fax: 412-623-4840; E-mail: chengs{at}upmc.edu or Bo Hu, Cancer Institute and Department of Medicine, University of Pittsburgh, HCCLB, 2.19f, 5117 Centre Avenue, Pittsburgh, PA 15213. Phone: 412-623-7791; Fax: 412-623-4840; E-mail: hub{at}upmc.edu.

A distinct feature of malignant gliomas is the intrinsic ability of single tumor cells to disperse throughout the brain, contributing to the failure of existing therapies to alter the progression and recurrence of these deadly brain tumors. Regrettably, the mechanisms underlying the inherent invasiveness of glioma cells are poorly understood. Here, we report for the first time that engulfment and cell motility 1 (ELMO1) and dedicator of cytokinesis 1 (Dock180), a bipartite Rac1 guanine nucleotide exchange factor (GEF), are evidently linked to the invasive phenotype of glioma cells. Immunohistochemical analysis of primary human glioma specimens showed high expression levels of ELMO1 and Dock180 in actively invading tumor cells in the invasive areas, but not in the central regions of these tumors. Elevated expression of ELMO1 and Dock180 was also found in various human glioma cell lines compared with normal human astrocytes. Inhibition of endogenous ELMO1 and Dock180 expression significantly impeded glioma cell invasion in vitro and in brain tissue slices with a concomitant reduction in Rac1 activation. Conversely, exogenous expression of ELMO1 and Dock180 in glioma cells with low level endogenous expression increased their migratory and invasive capacity in vitro and in brain tissue. These data suggest that the bipartite GEF, ELMO1 and Dock180, play an important role in promoting cancer cell invasion and could be potential therapeutic targets for the treatment of diffuse malignant gliomas. [Cancer Res 2007;67(15):7203–11]




This article has been cited by other articles:


Home page
Cancer Res.Home page
B. Hu, B. Shi, M. J. Jarzynka, J.-J. Yiin, C. D'Souza-Schorey, and S.-Y. Cheng
ADP-Ribosylation Factor 6 Regulates Glioma Cell Invasion through the IQ-Domain GTPase-Activating Protein 1-Rac1-Mediated Pathway
Cancer Res., February 1, 2009; 69(3): 794 - 801.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. Para, M. Krischke, S. Merlot, Z. Shen, M. Oberholzer, S. Lee, S. Briggs, and R. A. Firtel
Dictyostelium Dock180-related RacGEFs Regulate the Actin Cytoskeleton during Cell Motility
Mol. Biol. Cell, January 1, 2009; 20(2): 699 - 707.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
B. Salhia, N. L. Tran, A. Chan, A. Wolf, M. Nakada, F. Rutka, M. Ennis, W. S. McDonough, M. E. Berens, M. Symons, et al.
The Guanine Nucleotide Exchange Factors Trio, Ect2, and Vav3 Mediate the Invasive Behavior of Glioblastoma
Am. J. Pathol., December 1, 2008; 173(6): 1828 - 1838.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.